Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.

Simon R Procter Bronner P Gonçalves Proma Paul Jaya ChandnaFarah SeedatArtemis KoukounariRaymond C W HutubessyCaroline TrotterJoy E Lawn Mark Jit

Published in: PLoS medicine (2023)

In this study, we found that maternal GBS vaccination could have a large impact on infant morbidity and mortality. Globally, a GBS maternal vaccine at reasonable prices is likely to be a cost-effective intervention.

Keyphrases

birth weight
pregnancy outcomes
randomized controlled trial
public health
healthcare
mental health
gestational age
pregnant women
risk assessment
climate change
pseudomonas aeruginosa
social media
weight loss